Online Database of Chemicals from Around the World
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1443544-27-1 | 4,5-Bis(chloromethyl)-1,3-dioxol-2-one | Csub5/subHsub4/subClsub2/subOsub3/sub |
| 1443980-05-9 | 4-[(Methylsulfonyl)oxy]piperidine hydrochloride | Csub6/subHsub13/subNOsub3/subS.HCl |
| 1445085-55-1 | (SP-4-3)-[2'-(Amino)[1,1'-biphenyl]-2-yl][dicyclohexyl[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine](methanesulfonato)palladium;xphos pd g3 | Csub46/subHsub62/subNOsub3/subPPdS |
| 1445085-77-7 | [2'-(Amino)[1,1'-biphenyl]-2-yl][[2',6'-bis(1-methylethoxy)[1,1'-biphenyl]-2-yl]dicyclohexylphosphine](methanesulfonato)palladium;Methanesulfonato(2-dicyclohexylphosphino-2',6'-di-i-propoxy-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II) | Csub43/subHsub56/subNOsub5/subPPdS |
| 1445085-82-4 | [2'-(Amino)[1,1'-biphenyl]-2-yl][dicyclohexyl(2',6'-dimethoxy[1,1'-biphenyl]-2-yl)phosphine](methanesulfonato)palladium;SPhos Pd G3 | Csub39/subHsub48/subNOsub5/subPPdS |
| 1445085-87-9 | DavePhos-Pd-G3;2-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylaniline;methanesulfonic acid;palladium;2-phenylaniline | Csub39/subHsub50/subNsub2/subOsub3/subPPdSsup-/sup |
| 1445085-97-1 | Xantphos Pd G3;[2'-(Amino)[1,1'-biphenyl]-2-yl][[5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]diphenylphosphine](methanesulfonato)palladium | Csub52/subHsub45/subNOsub4/subPsub2/subPdS |
| 1445086-12-3 | Methanesulfonato(tricyclohexylphosphine)(2'-amino-1,1'-biphenyl-2-yl)palladium(II);P(Cy3) Pd G3 | Csub31/subHsub46/subNOsub3/subPPdS |
| 1445086-17-8 | [2'-(amino-κN)[1,1'-biphenyl]-2-yl-κC](methanesulfonato-κO)[tris(1,1-dimethylethyl)phosphine]-Palladium;tri-tert-butylphosphane | Csub25/subHsub40/subNOsub3/subPPdS |
| 1445086-28-1 | Methanesulfonato[1,1'-bis(diphenylphosphino)ferrocene)](2'-amino-1,1'-biphenyl-2-yl)palladium(II);DPPF Pd G3 | Csub47/subHsub33/subFeNOsub3/subPsub2/subPdS |
| 1445569-01-6 | 4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-Oxazolamine | Csub11/subHsub14/subNsub2/subO |
| 1445580-43-7 | 3-[(1R,2S,3S,4S)-2,3-Dihydroxy-4-(2-hydroxyethoxy)cyclopentyl]-3,6-dihydro-5-(propylthio)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one | Csub14/subHsub21/subNsub5/subOsub5/subS |
| 1445583-51-6 | N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | Csub21/subHsub23/subFNsub4/subOsub2/sub |
| 1445605-23-1 | (1S,2R)-N1-(3,4-Dichlorophenyl)-1,2-cyclohexanedicarboxamide | Csub14/subHsub16/subClsub2/subNsub2/subOsub2/sub |
| 1445684-99-0 | 3-[(2,2,2-Trifluoroethyl)thio]benzenamine | Csub8/subHsub8/subFsub3/subNS |
| 1445700-01-5 | (2R)-Tetrahydro-5-oxo-2-furancarboxylic acid [3-(trifluoromethyl)phenyl]methyl ester | Csub13/subHsub11/subFsub3/subOsub4/sub |
| 1445751-74-5 | AB-005 Azepane Isomer | Csub23/subHsub32/subNsub2/subO |
| 1445752-09-9 | N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide | Csub18/subHsub26/subNsub4/subOsub2/sub |
| 1445905-51-0 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-(2-methyl-1-oxopropyl)-guanosine 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] | Csub50/subHsub68/subNsub7/subOsub9/subPSi |
| 1445948-46-8 | (4R)-4-Fluoro-D-proline methyl ester hydrochloride (1:1) | Csub6/subHsub10/subFNOsub2/sub.HCl |
| 1445988-32-8 | N-(3-Methoxy-1,2,4-thiadiazol-5-yl)carbamic acid phenyl ester | Csub10/subHsub9/subNsub3/subOsub3/subS |
| 1445993-26-9 | Mivebresib;N-[4-(2,4-Difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide | Csub22/subHsub19/subFsub2/subNsub3/subOsub4/subS |
| 1445993-85-0 | 4-bromo-7-methoxy-1-tosyl-1H-pyrrolo[2,3-c]pyridine | Csub15/subHsub13/subBrNsub2/subOsub3/subS |
| 1446013-08-6 | Fmoc-His-Aib-OH TFA;2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(1H-imidazol-5-yl)propanamido]-2-methylpropanoic acid; trifluoroacetic acid | Csub25/subHsub26/subNsub4/subOsub5/sub.Csub2/subHFsub3/subOsub2/sub |
| 1446090-77-2 | rel-5-[[(1R,1aS,6bR)-1a,6b-Dihydro-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-cyclopropa[b]benzofuran-5-yl]oxy]-3,4-dihydro-1,8-naphthyridin-2(1H)-one | Csub25/subHsub17/subFsub3/subNsub4/subOsub3/sub |
| 1446144-04-2 | CPI 203;(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide | Csub19/subHsub18/subClNsub5/subOS |
| 1446194-56-4 | Bortezomib Impurity H;(S)-N-(1-(isopentylaMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | Csub19/subHsub24/subNsub4/subOsub2/sub |
| 1446261-44-4 | (10aR)-2-Fluoro-5,8,9,10,10a,11-hexahydro-10a-methyl-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(7H)-one | Csub16/subHsub15/subFNsub4/subO |
| 1446321-46-5 | 2-Hydroxy-6-[[2-[1-(1-methylethyl)-1H-pyrazol-5-yl]-3-pyridinyl]methoxy]benzaldehyde;GBT 440 | Csub19/subHsub19/subNsub3/subOsub3/sub |
| 1446448-94-7 | 4-(2-Naphthalenyl)-N-[4-(2-naphthalenyl)phenyl]benzenamine | Csub32/subHsub23/subN |
| 1446448-95-8 | 4-(1-Naphthalenyl)-N-[4-(2-naphthalenyl)phenyl]benzenamine | Csub32/subHsub23/subN |
| 1446502-11-9 | Enasidenib;2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol | Csub19/subHsub17/subFsub6/subNsub7/subO |
| 1446507-38-5 | 6-[6-(Trifluoromethyl)-2-pyridinyl]-1,3,5-triazine-2,4(1H,3H)-dione;2,4-Dichloro-6-[6-(trifluoromethyl)-2-pyridinyl]-1,3,5-triazine | Csub9/subHsub5/subFsub3/subNsub4/subOsub2/sub |
| 1446507-40-9 | 2,4-Dichloro-6-[6-(trifluoromethyl)-2-pyridinyl]-1,3,5-triazine;2,4-Dichloro-6-(6-trifluoromethyl-pyridin-2-yl)-1,3,5-triazine | Csub9/subHsub3/subClsub2/subFsub3/subNsub4/sub |
| 1446507-68-1 | 4-Chloro-6-[6-(trifluoromethyl)pyridin-2-yl]-N-[2-(trifluoromethyl)pyridin-4-yl]-1,3,5-triazin-2-amine | Csub15/subHsub7/subClFsub6/subNsub6/sub |
| 1446750-99-7 | 1,2-Bis(piperazin-1-yl)benzene;1,1'-(1,2-Phenylene)bis[piperazine] | Csub14/subHsub22/subNsub4/sub |
| 1446790-62-0 | 6-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[(5,6-dimethyl-2-pyridinyl)amino]-3-pyridazinecarboxamide;9021 | Csub18/subHsub25/subNsub7/subO |
| 1447607-90-0 | 6,7-Dichloro-2-methyl-1,2,3,4-tetrahydroquinoline | Csub10/subHsub11/subClsub2/subN |
| 1447671-73-9 | 3-Bromo-1,1,1-trifluoro-2,2-dimethylpropane | Csub5/subHsub8/subBrFsub3/sub |
| 1447709-01-4 | Benzo[b]naphtho[1,2-d]thien-5-ylboronic acid | Csub16/subHsub11/subBOsub2/subS |
| 1447715-44-7 | Bisoprolol EP Impurity B;1-(propan-2-ylamino)-3-[4-(2-propoxyethoxymethyl)phenoxy]propan-2-ol | Csub18/subHsub31/subNOsub4/sub |
| 1447715-45-8 | Bisoprolol N-Aldehyde;N-[2-hydroxy-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propyl]-N-propan-2-ylformamide | Csub19/subHsub31/subNOsub5/sub |
| 1447938-61-5 | Tris[4-(1,1-dimethylethyl)-2-(1H-pyrazol-1-yl)pyridine]cobalt salt with 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide (1:3) | Csub36/subHsub45/subCoNsub9/sub.3(Csub2/subFsub6/subNOsub4/subSsub2/sub) |
| 1447963-30-5 | 1-(2-Thienyl)cyclopropanemethanol | Csub8/subHsub10/subOS |
| 1447963-71-4 | 2-Diphenylphosphino-2',6'-bis(dimethylamino)-1,1'-biphenyl;2-(2-diphenylphosphanylphenyl)-1-N,1-N,3-N,3-N-tetramethylbenzene-1,3-diamine | Csub28/subHsub29/subNsub2/subP |
| 1447963-73-6 | CPhos Pd G3;Methanesulfonato(2-dicyclohexylphosphino-2',6'-bis(dimethylamino)-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II) | Csub41/subHsub54/subNsub3/subOsub3/subPPdS |
| 1447963-75-8 | [2'-(Amino)[1,1'-biphenyl]-2-yl][bis(1,1-dimethylethyl)[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine](methanesulfonato)palladium;Tbuxphos PD G3 | Csub42/subHsub58/subNOsub3/subPPdS |
| 1448169-71-8 | 1-[(3S)-3-[4-Amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]-2-propen-1-one | Csub22/subHsub22/subNsub6/subOsub3/sub |
| 1448185-87-2 | N-[[1,1'-Biphenyl]-4-yl]-4-dibenzothiophenamine | Csub24/subHsub17/subNS |
| 1448189-80-7 | (4R)-3-Methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-L-prolinamide hydrochloride (1:1);(S,R,S)-AHPC hydrochloride;VHL Ligand 1 (hydrochloride) | Csub22/subHsub30/subNsub4/subOsub3/subS.HCl |